In the oral cancer cells (HSC4, OSC19) that were used in this study, high expression of EGFR was confirmed, but no mutations of BRAF, HRAS, KRAS, and NRAS were observed. This evidence concerns the gene BRAF and lip and oral cavity carcinoma.